Cases 41 - 50 of 1,007
Taiho Pharmaceutical Co., Ltd. et al v. Eugia Pharma Specialities Ltd. et al
as 1:2023cv01193
Plaintiff:
Taiho Pharmaceutical Co., Ltd. and Taiho Oncology, Inc.
Counter Claimant:
Eugia Pharma Specialities Ltd.
Defendant:
Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Vincerx Pharma, Inc. v. Yourway Transport, Inc.
as 1:2023cv01164
Plaintiff:
Vincerx Pharma, Inc.
Defendant:
Yourway Transport, Inc.
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal
Celgene Corporation et al v. Natco Pharma Limited
as 1:2023cv01019
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Natco Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Intellectual Property Gmbh, et al. v. Auson Pharmaceuticals Inc., et al.
as 1:2023cv01103
Counter Defendant:
Bayer Intellectual Property GMBH
Plaintiff:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals Inc.
Defendant:
Auson Pharmaceuticals, Inc. and Auson Pharmaceuticals Co., Ltd.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Pfizer Inc. et al v. Zenara Pharma Private Limited
as 1:2023cv00924
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Zenara Pharma Private Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Aurobindo Pharma Limited
as 1:2023cv00923
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Aurobindo Pharma Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Pfizer Inc. et al v. Dexcel Pharma Technologies Limited
as 1:2023cv00879
Plaintiff:
Pfizer Inc., FoldRx Pharmaceuticals, LLC, PF PRISM IMB B.V. and others
Defendant:
Dexcel Pharma Technologies Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Orphalan SA v. Novitium Pharma LLC
as 1:2023cv01079
Plaintiff:
Orphalan SA
Defendant:
Novitium Pharma LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Lupin Ltd. et al
as 1:2023cv00819
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
